Xryem: Pharmaceutical Settlement Acceleration Clause Found A

On August 13, 2021, in a decision that largely flew under antitrust and patent practitioners' radars, U.S. District Judge Lucy H. Koh mostly denied a motion to dismiss in the alleged "reverse payment" case...

Related Keywords

Nate Raymond , Lucyh Koh , Brooke Grp , Amgen , While The Court , Us Senate , Jazz Pharmaceuticals , Actavis Inc , Gilead Scis Inc , Reuters , Supreme Court , Intl Medication Sys Ltd , Belcher Pharm , Judge Lucy , Hatch Waxman Act , Judge Koh , Favored Entry , Third Circuit , Generic Defendant , Ninth Circuit , Antitrust Litig , Namenda Indirect Purchaser Antitrust , Sensipar Cinacalcet Hydrochloride , Tablets Antitrust Litig , Williamson Tobacco , Medication Sys , Actos End Payor Antitrust Litig , Mondaq , Xryem Pharmaceutical Settlement Acceleration Clause Found Anticompetitive Due To Risk Of Quot Profit Crushing Competition , Anti Trust Competition Law , Antitrust , U Competition , Litigation , Ediation Amp Arbitration , Trials Amp Appeals Compensation , ,